Skip to main content
. 2020 Aug;9(3):130–136. doi: 10.5582/irdr.2020.03028

Table 3. Cost-utility analysis results.

Mean cost QALY ACER Incremental cost Incremental QALY ICER
No ERT 15,075 0.42174 35,745 366,777 3.78864 96,809
ERT 381,852 4.21038 90,693

ACER, average cost-effectiveness ratio; ERT, enzyme replacement therapy; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year.